Beijing Winsunny Pharmaceutical CO.LTD Cash Flow Reinvestment Rate
Beijing Winsunny Pharmaceutical CO.LTD cash flow reinvestment rate. Beijing Winsunny Pharmaceutical CO.LTD (601089) has a Cash Flow Reinvestment Rate of 0.58x as of December 2024, reinvesting CN¥403.39 Million (capex CN¥391.52 Million plus investments CN¥11.87 Million) from operating cash flow of CN¥690.75 Million. Explore cash flow to debt ratio of Beijing Winsunny Pharmaceutical CO.LTD to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Beijing Winsunny Pharmaceutical CO.LTD (2020–2024)
Cash flow reinvestment rate of Beijing Winsunny Pharmaceutical CO.LTD from 2020 to 2024. Historical reinvestment intensity for Beijing Winsunny Pharmaceutical CO.LTD across 5 annual periods. Explore 601089 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Beijing Winsunny Pharmaceutical CO.LTD Cash Flow Reinvestment Rate by Year (2020–2024)
Beijing Winsunny Pharmaceutical CO.LTD cash flow reinvestment rate by year from 2020 to 2024. Year-by-year capital reinvestment analysis for Beijing Winsunny Pharmaceutical CO.LTD. For the full cash flow conversion analysis, see Beijing Winsunny Pharmaceutical CO.LTD cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.58x | CN¥403.39 Million | CN¥690.75 Million | CN¥391.52 Million | ▼ -11.9% |
| 2023 | 0.66x | CN¥368.49 Million | CN¥555.90 Million | CN¥366.08 Million | ▲ +162.2% |
| 2022 | 0.25x | CN¥166.81 Million | CN¥659.76 Million | CN¥135.40 Million | ▼ -69.2% |
| 2021 | 0.82x | CN¥433.12 Million | CN¥528.02 Million | CN¥192.97 Million | ▼ -21.1% |
| 2020 | 1.04x | CN¥401.81 Million | CN¥386.65 Million | CN¥168.96 Million | — |